Sewoonmedical세운메디칼

Sewoonmedical is a profitable, lowly valued medical device maker whose recent filings are mostly routine housekeeping.

Sewoonmedical makes disposable medical devices such as suction units, catheters and infusion tubes, selling mainly to Korean hospitals with some exports to Europe and the US. On trailing twelve-month figures to H1 2026 it reported revenue of ₩66.5B, operating income of ₩14.3B and net income of ₩13.9B, with a net cash position of about ₩79.6B and no borrowings listed. The share price of ₩2,305 sits near the lower half of its 52-week range of ₩2,050 to ₩3,430.

What stands out

• Trailing operating margin of 21.5% is high, but operating income fell from ₩16.9B in 2023 to ₩12.7B in 2025, so profits have been volatile.
• Revenue grew 5.8% in 2025 after falling 11.9% in 2024, and the trailing figures are close to 2025 levels.
• Valuation metrics are low: about 7.3x P/E, 0.6x P/B and 1.5x P/S, with no dividend yield.
• A DCF-based model in the data gives a base value of ₩6,525 against the current ₩2,305, with a bear case of ₩5,130 and a bull case of ₩8,836; this is a model output, not a forecast.
• Recent filings are mostly routine: a share cancellation decision, a 5%+ holding report, the half-year report and board-related notices. No recent news headlines were provided.

What to watch

• The share cancellation decision filed on 2026-10-28 and its effect on the share count, which currently stands at 43.8M listed shares.
• Foreign ownership rose from 2.5% to 3.1% over the past 60 days, while institutions and retail were net sellers over the last 20 days.
• Upcoming full-year results, since the data only covers H1 2026 and the 2025 annual figures show profit has slipped from its 2023 peak; the data does not include any future guidance.